MAPT and Alzheimer disease: The same research group found that passive immunization with the monoclonal antibody 43D against the proximal N-terminal domain of Tau could reduce both Tau and Aβ pathology in 3×Tg-AD mice and that the N-terminal proximal domain of Tau was a more effective target for passive immunization than the N-terminal distal domains of Tau [113].